Kraig Biocraft Laboratories Closes Additional Funding Agreement
Robust financial strength positions Company to deploy Impact CapitalANN ARBOR, Mich., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories,...
News
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2021
NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical company...
Circulating Tumor Cell (CTC) Isolation with TellDx Technology Could Inform Personalized Drug Treatment in Prostate Cancer
-- Single-cell proteomics can elucidate kinase activity in prostate cancer models -- -- Kinase activity in bone metastases and epithelial...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business...
Oncternal Therapeutics Hosting Key Opinion Leader Webinar on Hematological Malignancies and Prostate Cancer
Session will include a discussion of the treatment landscape for Mantle Cell Lymphoma, including potential role of Zilovertamab, Oncternal’s ROR1...
ASLAN Pharmaceuticals Initiates Phase 2b Study of ASLAN004 (Eblasakimab) in Moderate-to-Severe Atopic Dermatitis
The TRials with EblasaKimab in Atopic Dermatitis (TREK-AD) study will evaluate the efficacy and safety of ASLAN004, now known as...
Intuitive Announces Fourth Quarter Earnings
SUNNYVALE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive...
Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022
Oak Ridge, TN, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement...
Maravai LifeSciences Announces Debt Repricing
Lowers Interest Rates on Current Debt to Provide Approximately $6.8 Million in Annual Interest SavingsSAN DIEGO, Jan. 20, 2022 (GLOBE...
Kura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Acute Myeloid Leukemia
– FDA lifts partial clinical hold following agreement on mitigation strategy for differentiation syndrome – – KOMET-001 study to resume...
Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA
SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission...
Inventiva announces participation at several conferences in January and February 2022
Daix (France), Long Island City (New York, United States), January 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a...
EssilorLuxottica : EssilorLuxottica appoints new member to its Board of Directors
EssilorLuxottica appoints new member to its Board of Directors As the new Valoptec Association President, Virginie Mercier Pitre replaces Juliette...
MS Read-a-Thon Makes a Difference in the Lives of Canadians Impacted by MS, One Book at a Time
Long-time fundraiser kicks-off with a virtual book club event, awakening a love for reading in children while supporting the Canadian...
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2021 Financial Results Conference Call
WOBURN, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its...
Wound Care Commercialization to be a Key Company Focus in 2022
New video blog series part of 2022 commitment to increase and broaden communication to investorsWINNIPEG, Manitoba, Jan. 20, 2022 (GLOBE...
Yingli Pharma and MD Anderson Initiate Strategic Collaboration to Advance Development of Multiple Oncology Programs
Five-year collaboration to provide support for clinical and preclinical efforts as Yingli Pharma expands its U.S. presence with robust oncology...
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty...
Osmind Announces Appointment of Brent Saunders, Pharma Veteran and Former CEO of Allergan, to Board of Directors
Mr. Saunders will serve on Osmind’s Board of Directors and brings decades of leadership in healthcare and life sciences, including...